Atlas Trials

Clinical Trial of the BioMed rTSST-1 Variant Vaccine in Healthy Adults

Clinical trial NCT02814708 · COMPLETED

Trial details

NCT number
NCT02814708
Sponsor
Biomedizinische Forschungs gmbH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Toxic Shock Syndrome
Start date
2016-05-01
Primary completion
2020-05-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.